330913 RESULTS
CONFERENCE COVERAGE 2013-08-18 Conference Coverage This is part 1 of a two-part series. See Part 2. Proposed research criteria for AD employ biomarkers to identify several stages of preclinical disease, and since their publication in 2011 the field has been pushing hard to test how wel
CONFERENCE COVERAGE 2013-08-18 Conference Coverage This is part 2 of a two-part series. See Part 1 Since the advent of brain amyloid imaging, researchers have been surprised to find that a substantial minority of people clinically diagnosed with Alzheimer’s disease have no detectable a
PAPER Vengoechea J, David MP, Yaghi SR, Carpenter L, Rudnicki SA
PAPER Benarroch EE
PAPER Waters C
PAPER Chen DL, Zhang P, Lin L, Zhang HM, Liu SH
PAPER Kim SJ, Lee JH, Chung HS, Song JH, Ha J, Bae H
PAPER Stephan AH, Madison DV, Mateos JM, Fraser DA, Lovelett EA, Coutellier L, Kim L, Tsai HH, Huang EJ, Rowitch DH, Berns DS, Tenner AJ, Shamloo M, Barres BA
PAPER Ricard MJ, Gudas LJ
PAPER Feng HL, Li RS, Wang H, Ren Y, Sun HY, Yang JD, Wang PW
PAPER Dang HZ, Li RS, Wang H, Ren Y, Sun HY, Yang JD, Wang PW
PAPER Painter J
PAPER Ishii K
PAPER Zuelsdorff ML, Engelman CD, Friedman EM, Koscik RL, Jonaitis EM, Rue AL, Sager MA
PAPER Jedidi H, Feyers D, Collette F, Bahri MA, Jaspar M, D'Argembeau A, Salmon E, Bastin C
No filters selected
